The chairman of BioSingapore, Dr. Siew Hwa Ong, discusses the opportunities and challenges facing biotech SMEs in Singapore, government efforts to enhance the business environment for these SMEs, and facilitating more collaboration between companies as the most prominent pathway for future development.
Could you please introduce yourself to our international readers as well as the main purpose of BioSingapore?
Since its establishment, BioSingapore has increased its membership and now has more than 100 associated individuals and around 30 member companies.
